Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncol Lett. 2013 Feb;5(2):684-688. Epub 2012 Nov 15.

Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded.

Author information

  • 1Trend Research Centre, Asia University, Taichung 41354, Taiwan ;

Abstract

This study was conducted to explore a bibliometric approach to quantitatively assess current research trends in cisplatin-containing chemotherapy for small cell lung cancer (SCLC), using related literature in the Science Citation Index Expanded database from 1992 to 2011. Articles were analyzed by the scientific output and research performances of countries and institutions. The distribution of key words in the article title and author-selected keywords were used to evaluate research trends. It was observed that the number of articles devoted to cisplatin-containing chemotherapy for SCLC did not increase with time. The USA and Japan were the top two countries with the highest number of articles devoted to cisplatin-containing chemotherapy for SCLC. In both countries, the number of articles did not increase with time, and a decreasing trend was identified in the USA over the last 10 years. This study demonstrates trends in cisplatin-containing chemotherapy for SCLC. The clinical application of novel drugs is required for successful SCLC treatment.

KEYWORDS:

bibliometric; cisplatin; small cell lung cancer; web of science

PMID:
23420619
PMCID:
PMC3573148
DOI:
10.3892/ol.2012.1029
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center